Aptose Biosciences (TSE:APS)
TSX:APS
Holding TSE:APS?
Track your performance easily

Aptose Biosciences (APS) Financial Statements

130 Followers

Aptose Biosciences Financial Overview

Aptose Biosciences's market cap is currently ―. The company's EPS TTM is C$-5.996; its P/E ratio is -0.09; Aptose Biosciences is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is C$-0.89. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.25M$ -9.64M$ -11.96M$ -11.45M$ -14.13M
EBITDA$ -7.15M$ -9.53M$ -11.85M$ -11.34M$ -14.15M
Net Income Common Stockholders$ -7.25M$ -9.64M$ -11.96M$ -11.45M$ -14.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.33M$ 9.33M$ 9.25M$ 17.72M$ 23.31M
Total Assets$ 10.95M$ 11.95M$ 12.05M$ 20.88M$ 26.57M
Total Debt$ 818.00K$ 919.00K$ 1.01M$ 1.11M$ 1.20M
Net Debt$ -7.51M$ -8.41M$ -8.24M$ -16.61M$ -22.10M
Total Liabilities$ 13.13M$ 12.66M$ 15.89M$ 13.10M$ 12.79M
Stockholders Equity$ -2.18M$ 137.00K$ -2.90M$ 7.78M$ 13.79M
Cash Flow-
Free Cash Flow$ -5.76M$ -11.76M$ -9.26M$ -10.54M$ -2.23M
Operating Cash Flow$ -5.78M$ -11.76M$ -9.26M$ -10.54M$ -2.20M
Investing Cash Flow$ 2.01M$ -1.99M$ 1.94M$ 12.95M$ 1.00M
Financing Cash Flow$ 4.75M$ 11.85M$ 854.00K$ 4.90M$ 1.05M
Currency in USD

Aptose Biosciences Earnings and Revenue History

Aptose Biosciences Debt to Assets

Aptose Biosciences Cash Flow

Aptose Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis